Caprock Group’s Tenet Healthcare THC Stock Holding History

Caprock Group’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.06M	Sell	5,666 -899	-14%	-$165K	0.02%	612
2026 Q1	$1.24M	Sell	6,565 -2,115	-24%	-$446K	0.03%	482
2025 Q4	$1.72M	Buy	8,680 +638	+8%	+$129K	0.04%	427
2025 Q3	$1.48M	Buy	+8,042	New	+$1.43M	0.04%	435
2025 Q1	$619K	Buy	4,602 +938	+26%	+$124K	0.02%	633
2024 Q4	$463K	Sell	3,664 -258	-7%	-$38.4K	0.02%	648
2024 Q3	$652K	Buy	3,922 +337	+9%	+$51K	0.02%	501
2024 Q2	$477K	Buy	+3,585	New	+$432K	0.02%	546
2022 Q2	–	Sell	-2,890	Closed	-$248K	–	630
2022 Q1	$248K	Hold	2,890	–	–	0.02%	493
2021 Q4	$236K	Buy	+2,890	New	+$211K	0.02%	506

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Caprock Group's THC Position: Q2 2026 in Review

Caprock Group reduced its Tenet Healthcare (THC) stake by 14% in Q2 2026, selling an estimated $165K and leaving 5,666 shares worth $1.06M. The position accounts for 0.02% of the portfolio, ranked #612.

Caprock Group first reported a position in THC in Q4 2021 and has held it in 10 quarters since. The position peaked at $1.72M in Q4 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

Caprock Group held 5,666 shares of Tenet Healthcare worth $1.06M as of Q2 2026.
Caprock Group sold 899 Tenet Healthcare shares in Q2 2026, an estimated $165K.
Tenet Healthcare made up 0.02% of Caprock Group's portfolio in Q2 2026, its #612 holding.
Caprock Group first reported a position in Tenet Healthcare in Q4 2021 and has held it in 10 quarters since.
Caprock Group's Tenet Healthcare position peaked at $1.72M in Q4 2025.
679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.